Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ASAP3 Antikörper

ASAP3 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN539512
  • Target Alle ASAP3 Antikörper anzeigen
    ASAP3 (ArfGAP with SH3 Domain, Ankyrin Repeat and PH Domain 3 (ASAP3))
    Reaktivität
    • 30
    • 16
    • 16
    • 9
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 44
    • 1
    Kaninchen
    Klonalität
    • 45
    Polyklonal
    Konjugat
    • 17
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ASAP3 Antikörper ist unkonjugiert
    Applikation
    • 39
    • 21
    • 16
    • 13
    • 13
    • 8
    • 3
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Verwendungszweck
    Rabbit polyclonal antibody raised against recombinant ASAP3.
    Kreuzreaktivität
    Human, Maus, Ratte
    Produktmerkmale
    Antibody Reactive Against Recombinant Protein.
    Immunogen
    Recombinant protein corresponding to human ASAP3.
    Top Product
    Discover our top product ASAP3 Primärantikörper
  • Applikationshinweise
    ELISA (1:1000-1:5000)
    Western Blot (1:1000-1:10000)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In 20 mM KH2PO4, 150 mM NaCl, pH 7.2 (0.01 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Inoue, Randazzo: "Arf GAPs and their interacting proteins." in: Traffic (Copenhagen, Denmark), Vol. 8, Issue 11, pp. 1465-75, (2007) (PubMed).

    Onodera, Hashimoto, Hashimoto, Morishige, Mazaki, Yamada, Ogawa, Adachi, Sakurai, Manabe, Wada, Matsuura, Sabe: "Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities." in: The EMBO journal, Vol. 24, Issue 5, pp. 963-73, (2005) (PubMed).

    Okabe, Furukawa, Kato, Hasegawa, Yamaoka, Nakamura: "Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas." in: International journal of oncology, Vol. 24, Issue 1, pp. 43-8, (2003) (PubMed).

  • Target
    ASAP3 (ArfGAP with SH3 Domain, Ankyrin Repeat and PH Domain 3 (ASAP3))
    Andere Bezeichnung
    DDEFL1 (ASAP3 Produkte)
    Synonyme
    DDEFL1 antikoerper, ddefl1 antikoerper, zgc:113885 antikoerper, ACAP4 antikoerper, CENTB6 antikoerper, UPLC1 antikoerper, 9430088F20Rik antikoerper, Ddefl1 antikoerper, Gm140 antikoerper, ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 antikoerper, development and differentiation enhancing factor-like 1 antikoerper, ASAP3 antikoerper, asap3 antikoerper, DDEFL1 antikoerper, Asap3 antikoerper
    Gen-ID
    55616
Sie sind hier:
Kundenservice